AU4245097A - Multivalent vaccine for (clostridium botulinum) neurotoxin - Google Patents
Multivalent vaccine for (clostridium botulinum) neurotoxinInfo
- Publication number
- AU4245097A AU4245097A AU42450/97A AU4245097A AU4245097A AU 4245097 A AU4245097 A AU 4245097A AU 42450/97 A AU42450/97 A AU 42450/97A AU 4245097 A AU4245097 A AU 4245097A AU 4245097 A AU4245097 A AU 4245097A
- Authority
- AU
- Australia
- Prior art keywords
- neurotoxin
- clostridium botulinum
- multivalent vaccine
- multivalent
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000193155 Clostridium botulinum Species 0.000 title 1
- 101710138657 Neurotoxin Proteins 0.000 title 1
- 229940031348 multivalent vaccine Drugs 0.000 title 1
- 239000002581 neurotoxin Substances 0.000 title 1
- 231100000618 neurotoxin Toxicity 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/704,159 US6967088B1 (en) | 1995-03-16 | 1996-08-28 | Soluble recombinant botulinum toxin proteins |
US08704159 | 1996-08-28 | ||
PCT/US1997/015394 WO1998008540A1 (en) | 1996-08-28 | 1997-08-28 | Multivalent vaccine for clostridium botulinum neurotoxin |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4245097A true AU4245097A (en) | 1998-03-19 |
Family
ID=24828333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU42450/97A Abandoned AU4245097A (en) | 1996-08-28 | 1997-08-28 | Multivalent vaccine for (clostridium botulinum) neurotoxin |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1105153A4 (en) |
AU (1) | AU4245097A (en) |
CA (1) | CA2296765A1 (en) |
WO (1) | WO1998008540A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7214787B1 (en) * | 1993-09-21 | 2007-05-08 | United States Of America As Represented By The Secretary Of The Army | Recombinant vaccine against botulinum neurotoxin |
GB9617671D0 (en) | 1996-08-23 | 1996-10-02 | Microbiological Res Authority | Recombinant toxin fragments |
US8012491B2 (en) | 1996-08-23 | 2011-09-06 | Syntaxin, Ltd. | Recombinant toxin fragments |
US7192596B2 (en) | 1996-08-23 | 2007-03-20 | The Health Protection Agency Ipsen Limited | Recombinant toxin fragments |
GB9721189D0 (en) | 1997-10-08 | 1997-12-03 | Speywood Lab The Limited | Analgesic conjugates |
ATE382693T1 (en) * | 1998-07-10 | 2008-01-15 | U S Army Medical Res Inst Of I | VACCINES AGAINST CLOSTRIDIUM BOTULINUM NEUROTOXINS |
AU4641299A (en) * | 1998-07-22 | 2000-02-14 | Agricultural Research Council | Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin |
US20040071736A1 (en) | 1998-08-25 | 2004-04-15 | Health Protection Agency | Methods and compounds for the treatment of mucus hypersecretion |
GB9818548D0 (en) | 1998-08-25 | 1998-10-21 | Microbiological Res Authority | Treatment of mucas hypersecretion |
GB9907429D0 (en) | 1999-03-31 | 1999-05-26 | Microbiological Res Authority | Modulation of C-fibre activity |
CA2380457A1 (en) | 1999-08-25 | 2001-03-01 | Allergan Sales, Inc. | Activatable recombinant neurotoxins |
US7740868B2 (en) | 1999-08-25 | 2010-06-22 | Allergan, Inc. | Activatable clostridial toxins |
US20080038274A1 (en) | 1999-09-23 | 2008-02-14 | Foster Keith A | Inhibition of secretion from non-neuronal cells |
US7691983B2 (en) | 2000-07-21 | 2010-04-06 | Allergan, Inc. | Chimera botulinum toxin type E |
AU2002228887B2 (en) * | 2000-11-06 | 2006-08-24 | United States Army Medical Research And Material Command | Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
JP3995541B2 (en) * | 2002-06-28 | 2007-10-24 | 株式会社ゲン・コーポレーション | Anti-chicken coccidiosis composition |
US20050042775A1 (en) * | 2003-08-21 | 2005-02-24 | Nicholas Pomato | Botulinum antitoxin compositions and methods |
GB2456549A (en) * | 2008-01-18 | 2009-07-22 | Health Prot Agency | Modified botulinum neurotoxin serotype E (BoNT/E) peptides |
WO2009152452A1 (en) * | 2008-06-12 | 2009-12-17 | Huei-Hsiung Yang | Fermentation method for the production of soluble botulinum neurotoxin proteins |
RU2014127714A (en) | 2011-12-08 | 2016-01-27 | Новартис Аг | TOXIN VACCINE Clostridium difficile |
DK3372239T3 (en) | 2012-05-30 | 2021-02-01 | Harvard College | MANIPULATED BOTULINUM NEUROTOXIN |
EP3981783A1 (en) | 2015-03-26 | 2022-04-13 | President And Fellows Of Harvard College | Engineered botulinum neurotoxin |
KR20180021703A (en) | 2015-05-15 | 2018-03-05 | 보드 오브 리젠츠 오브 디 유니버시티 오브 네브라스카 | The engineered Clostridium botulinum toxin, modified to deliver the molecule to selected cells |
WO2018039506A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Engineered botulinum neurotoxin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996005222A1 (en) * | 1994-08-08 | 1996-02-22 | Wisconsin Alumni Research Foundation | Purification and pharmaceutical compositions containing type g botulinum neurotoxin |
CZ296806B6 (en) * | 1994-10-24 | 2006-06-14 | Allergan, Inc. | Soluble fusion protein and process for preparing soluble recombinant botulin toxin |
-
1997
- 1997-08-28 WO PCT/US1997/015394 patent/WO1998008540A1/en active Application Filing
- 1997-08-28 EP EP97940746A patent/EP1105153A4/en not_active Ceased
- 1997-08-28 AU AU42450/97A patent/AU4245097A/en not_active Abandoned
- 1997-08-28 CA CA002296765A patent/CA2296765A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1105153A4 (en) | 2005-01-19 |
EP1105153A1 (en) | 2001-06-13 |
WO1998008540A1 (en) | 1998-03-05 |
CA2296765A1 (en) | 1998-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4245097A (en) | Multivalent vaccine for (clostridium botulinum) neurotoxin | |
AU2103797A (en) | Clostridium perfringens vaccines | |
AU3821497A (en) | Methods for isolating nucleic acids using alkaline protease | |
AU1848597A (en) | Emulation repair system | |
AU6051798A (en) | Method and system for injecting new code into existing application code | |
AU4781297A (en) | Vaccines | |
AU3773297A (en) | Intradermal bovine polynucleotide vaccine | |
AU3593697A (en) | Asymmetrical drive system | |
AU3992697A (en) | Pharmaceutical preparations for intranasal administration | |
HK1083736A1 (en) | Immunization against clostridium difficile disease | |
AU1847497A (en) | Protein expression system | |
HK1019499A1 (en) | Optical disc and optical disc driving apparatus. | |
AU3058397A (en) | Information system | |
AU4391197A (en) | Sealing system | |
AU8348298A (en) | Split-key cryptographic system and method | |
AU4528496A (en) | Method for generating proteolytic enzymes specific against selected peptide sequence | |
HUP9801384A3 (en) | Clostridium perfringens vaccine | |
AU5256998A (en) | Electrophoresis system | |
AUPO182396A0 (en) | Improved nucleic acids for reducing carbohydrate epitopes | |
AU7361798A (en) | Method and system for wavelength division multiplexer | |
AU4747997A (en) | Interstitial sector system | |
AU4879797A (en) | Optical system for head up display | |
AU3552797A (en) | Vaccine preparations | |
AU4641299A (en) | Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin | |
GB2327291B (en) | Optical system for optical disk drive |